Citations 1
A phase I dose-escalation and pharmacokinetic (PK) study of a novel multiple-targeted receptor tyrosine kinase (RTK) inhibitor, XL647, in patients with advanced solid malignancies
Wakelee, Heather A. , Adjei, Alex A. , Halsey, Joanne, Hanson, L., Hutchison, S , Piens, Jill, Lacy, Steven , Šikić, Branimir I. , Keer, Harold N , Reid, Joel M.
Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3142-3142
